Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
Main Authors: | Koblin B, Metch B, Morgan C, Novak R, Swann E, Metzger D, Lucy D, Dunbar D, Graham P, Madenwald T, Escamia G, Frank I |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | Retrovirology |
Similar Items
-
US patent no. 8,000,906 B2: Digital flowmeter
by: Henry, M, et al.
Published: (2011) -
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
by: Moodie Z, et al.
Published: (2009-10-01) -
P15-15. Advocates' perspectives on community engagement in the HVTN 505
by: Miller L, et al.
Published: (2009-10-01) -
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
by: Blattner William A
Published: (2005-12-01) -
Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)
by: Wing Lam, et al.
Published: (2018-11-01)